Due to its specific structure, this construct has the ability to turn off the N-myc gene, which promotes the progression of neuroblastoma and the presence of fluorescent drugs encapsulated into liposomes enables in vivo imaging of nanoconstruct transport into the target cell. The gene discussed is MYCN; the disease is neuroblastoma.